182 related articles for article (PubMed ID: 10980996)
1. Therapy for H. pylori infection.
Thomson AB
Curr Gastroenterol Rep; 1999 Dec; 1(6):518-23. PubMed ID: 10980996
[TBL] [Abstract][Full Text] [Related]
2. Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
Aliment Pharmacol Ther; 2000 Aug; 14(8):991-9. PubMed ID: 10930892
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine bismuth citrate.
Chiba N; Hunt RH; Thomson AB
Can J Gastroenterol; 2001 Jun; 15(6):389-98. PubMed ID: 11429668
[TBL] [Abstract][Full Text] [Related]
5. One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Hung WK; Wong WM; Wong GS; Yip AW; Szeto ML; Lai KC; Hu WH; Chan CK; Xia HH; Yuen MF; Fung FM; Tong TS; Ho VY; Lam SK; Wong BC
Aliment Pharmacol Ther; 2002 Dec; 16(12):2067-72. PubMed ID: 12452939
[TBL] [Abstract][Full Text] [Related]
6. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
Janssen MJ; Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
Aliment Pharmacol Ther; 2001 May; 15(5):613-24. PubMed ID: 11328254
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
Paré P; Farley A; Romãozinho JM; Bardhan KD; French PC; Roberts PM
Aliment Pharmacol Ther; 1999 Aug; 13(8):1071-8. PubMed ID: 10468683
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
[TBL] [Abstract][Full Text] [Related]
9. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Sung JJ; Leung WK; Ling TK; Yung MY; Chan FK; Lee YT; Cheng AF; Chung SC
Aliment Pharmacol Ther; 1998 Aug; 12(8):725-30. PubMed ID: 9726384
[TBL] [Abstract][Full Text] [Related]
10. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
12. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Catalano F; Branciforte G; Catanzaro R; Cipolla R; Bentivegna C; Brogna A
Aliment Pharmacol Ther; 2000 Oct; 14(10):1329-34. PubMed ID: 11012478
[TBL] [Abstract][Full Text] [Related]
14. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
15. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
16. Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori.
Pipkin GA; Williamson R; Wood JR
Aliment Pharmacol Ther; 1998 Sep; 12(9):823-37. PubMed ID: 9768524
[TBL] [Abstract][Full Text] [Related]
17. Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication.
Santolaria S; Guirao R; Ducóns J; Cabezudo JG; Montoro M; Gomollon F
J Clin Gastroenterol; 2001 Jan; 32(1):90-1. PubMed ID: 11154181
[No Abstract] [Full Text] [Related]
18. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Gisbert JP; Gonzalez L; Calvet X
Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
[TBL] [Abstract][Full Text] [Related]
19. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
